DYN Dyne Therapeutics, Inc.
$16.94▲ +7.76%
Healthcare
Other
After hours
$16.61▼ -1.95%
Oct 27, 4:31 PM ET
Volume 3.00M
Avg Volume (10D) 2.49M
Key Metrics & Fundamentals
Market Cap
$3.16B
P/E Ratio
–
Div Yield
0.00%
52W Range
14.00 - 27.31
% vs 50 MA
-11.27%
% vs 200 MA
-12.29%
RSI-14
52.2
MACD Histogram
+0.3600
Beta (1Y vs SPY)
1.84
Free Cash Flow
-$131.80M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$173.40M
COGS
–
Operating Exp
$181.66M
Operating Income
-$181.66M
EBIT
-$181.66M
Pretax Income
-$178.56M
Net Income
-$178.56M
EPS (Diluted)
-1.08
Price & Volume History
Loading chart…
Recent News
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 22, 2026 4:05 PM ET
Top 4 Healthcare Stocks Backed by Raymond James Analysts
Investing.com · Oct 8, 2026 10:09 AM ET
Why Dyne Therapeutics (DYN) Is Back In The Spotlight
Simply Wall St. · Oct 7, 2026 10:12 AM ET
Dyne Therapeutics stock rises on positive DM1 trial results
Investing.com · Sep 29, 2026 5:23 PM ET
Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
GlobeNewswire · Sep 29, 2026 4:05 PM ET
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 17, 2026 4:05 PM ET
Do Dyne Therapeutics’ (DYN) Expanded DM1 Data Presentations Redefine Its Rare-Disease Investment Narrative?
Simply Wall St. · Sep 17, 2026 12:13 PM ET
Wall Street Weighs Impact On DYN Stock Post Novartis’ Phase 3 Failure — RBC Says These Key Differences Could Lead To Better Outcomes
Stocktwits · Sep 9, 2026 11:41 AM ET
Dyne Therapeutics Myotonic Dystrophy Approach Remains Differentiated, RBC Says
MT Newswires · Sep 9, 2026 11:10 AM ET
Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls
The Fly · Sep 9, 2026 9:51 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See DYN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.